Crossmark Global Holdings’s LeMaitre Vascular LMAT Stock Holding History

Crossmark Global Holdings’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,850	Closed	-$202K	–	1290
2026 Q1	$202K	Buy	+1,850	New	+$176K	﹤0.01%	1201
2021 Q4	–	Sell	-4,750	Closed	-$252K	–	1429
2021 Q3	$252K	Sell	4,750 -480	-9%	-$27K	0.01%	1248
2021 Q2	$319K	Sell	5,230 -150	-3%	-$7.97K	0.01%	1147
2021 Q1	$262K	Sell	5,380 -530	-9%	-$24.8K	0.01%	1242
2020 Q4	$239K	Buy	+5,910	New	+$211K	0.01%	1226
2018 Q4	–	Sell	-9,050	Closed	-$351K	–	1478
2018 Q3	$351K	Sell	9,050 -80	-0.9%	-$2.88K	0.01%	1206
2018 Q2	$306K	Buy	9,130 +580	+7%	+$20.6K	0.01%	1289
2018 Q1	$310K	Sell	8,550 -320	-4%	-$11.1K	0.01%	1245
2017 Q4	$282K	Hold	8,870	–	–	0.01%	1405
2017 Q3	$332K	Buy	+8,870	New	+$302K	0.01%	1247
2016 Q3	$332K	Buy	+8,870	New	+$155K	0.01%	1247

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Crossmark Global Holdings's LMAT Position: Q2 2026 in Review

Crossmark Global Holdings sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,850 shares — an estimated $202K sold.

Crossmark Global Holdings first reported a position in LMAT in Q3 2016 and held it in 11 quarters. The position peaked at $351K in Q3 2018. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Crossmark Global Holdings reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
Crossmark Global Holdings sold 1,850 LeMaitre Vascular shares in Q2 2026, an estimated $202K.
Crossmark Global Holdings first reported a position in LeMaitre Vascular in Q3 2016 and held it in 11 quarters.
Crossmark Global Holdings's LeMaitre Vascular position peaked at $351K in Q3 2018.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.